Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
about
Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regenerationMicroRNAs: new players in cardiac injury and protectionThe Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: RevisitedThe hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regenerationHIF hydroxylase pathways in cardiovascular physiology and medicinePHD2: from hypoxia regulation to disease progressionMolecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseasesActivation of the prolyl-hydroxylase oxygen-sensing signal cascade leads to AMPK activation in cardiomyocytesCardiac Gene Expression Knockdown Using Small Inhibitory RNA-Loaded Microbubbles and Ultrasound.P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseHypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells.Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injuryRole of microRNAs in cardiac preconditioningRedox signaling in cardiac myocytes.Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cellsWound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.Rejuvenation: an integrated approach to regenerative medicine.Hypoxia-inducible factors and the prevention of acute organ injury.Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioningEffect of conjugated linoleic acid on inhibition of prolyl hydroxylase 1 in hearts of miceIsoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure.Inflammatory response in microvascular endothelium in sepsis: role of oxidants.EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism.CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.Short hairpin RNA interference therapy for ischemic heart diseaseCharacterization of eicosanoid synthesis in a genetic ablation model of ceramide kinaseAng-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemiaRole of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion.HIF-1α in heart: protective mechanisms.Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.The role of autophagy in the heart.Redox signaling in cardiovascular health and disease.Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus.Hypoxia inducible factor 1 (HIF-1) and cardioprotection.Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy.
P2860
Q24613344-2DE0D735-284E-49B3-8330-628DCAEEA37EQ24635236-28558DE8-E7C4-4B68-9FC3-23761924B0ECQ26744642-581B5E56-2C7B-408F-A638-E37872BD8345Q26861237-FD102D25-12DA-48A2-98FF-5BE0B23B5462Q26862091-C3FF227D-F5A7-4F58-B583-F60CBBBCBE24Q28069316-8814BC0C-573B-4EFB-B42A-09DDE8E4324BQ28297656-B2DA1170-55A1-4CB0-BAB4-546A93B2CE31Q28580371-8EA0BD04-C38D-4780-A022-6202D29BA5FFQ30376315-016ED90A-4E44-4726-BA0C-5160A02149A0Q30409205-830F67EE-14E5-4105-9310-F959E77FDC65Q30449821-439D86BF-1BF2-43A9-A671-AC290FC73A34Q33331198-E003DB66-5655-4B40-A4E2-ED1A1E2174E5Q33810031-08DBF646-7049-4B26-BAD0-2987BAA10A8AQ34503344-090DEEBC-BAD9-40D0-B4F7-E23A7AB07232Q34629326-3FBE1DAD-EA8A-413C-AA3E-702A69C9D084Q35022857-852D8102-A20F-4A6A-B885-C081612483CAQ35078425-ED9CEA7C-BB02-4557-A0DB-EDD45E3E17CFQ35219366-234029E1-6E6D-443F-A0A4-8BE5ABDDFCF8Q35222931-FAE12795-827E-4058-9485-5A8419DF9FF2Q35559650-71D1782F-1628-47E8-9181-9B00591D70DFQ35677054-AD9F6CE6-B7A9-4D2D-AC9A-2E754CFE1051Q35808866-4D37D7B0-5DB7-447D-A013-5627B628BE29Q36411613-DAE7DD5F-015D-4167-A80C-2A0B57C69640Q36491882-695494E6-4A18-46F3-A279-273502328966Q36661663-39A3AFAB-20B1-4812-A15A-78407E6CCFDCQ36762987-0790213D-729D-4A12-98D7-17583632BADBQ36835045-7733902A-04F3-4BD8-849A-8B66556C71D5Q36842525-53590B5C-9107-4AC1-B4D8-839F47A54B59Q36853941-DCCFC9A7-CB72-4C0E-9208-BD2E6CCCAE4EQ36920571-907B3B67-4B11-433C-9433-D8F6BD63C707Q36975496-B791402D-B18F-4452-BC5A-77F7C4590CDEQ37045533-F28F01C0-7275-490A-8F67-F644EEBDDCFFQ37079721-8D8CAAF9-168E-4ED1-8A23-D97628B5B187Q37142770-058F9290-EA36-4AEE-86C3-70193A866B7BQ37218014-AABFE406-1CF1-44DA-A0C3-C49215666690Q37325466-6FB13A6E-5D82-4F85-9659-AC35AAFAB31EQ37446110-49709563-9FB1-495F-A834-E7986C5E0079Q37680288-7FB7DA1A-7325-4C63-8E6A-C601AF4BD388Q37780103-1C933B67-2C18-4A34-BAE6-FCFDCEED61F0Q38577907-D48AA3F8-83B3-4185-AB5B-ACDBF2248180
P2860
Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@en
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@nl
type
label
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@en
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@nl
prefLabel
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@en
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@nl
P2093
P921
P1433
P1476
Hypoxia inducible factor-1 act ...... l ischemia reperfusion injury.
@en
P2093
Alpha A Fowler
Bernard J Fisher
Fadi N Salloum
Rakesh C Kukreja
P304
P356
10.1161/01.RES.0000197816.63513.27
P577
2005-11-23T00:00:00Z